Early diagnosis of Cryptococcus neoformans var. grubii meningitis using multiplex PCR assay in an immunocompetent

Yoshinori Takahashi1, Ryosuke Osawa1, Yoshifumi Kubota1

  • 1Department of Infectious Diseases, Kameda Medical Center, 929 Higashi-cho, Kamogawa, Chiba, Japan.

Insights

A multiplex PCR assay unexpectedly identified Cryptococcus in an immunocompetent man, enabling rapid treatment for fungal meningitis. This highlights PCR

Area of Science:

  • Infectious Diseases
  • Mycology
  • Neurology

Background:

  • Cryptococcosis, a fungal infection, typically affects immunocompromised individuals.
  • Increasing cases of cryptococcosis are reported in immunocompetent individuals.
  • Heavy alcohol consumption may be a risk factor in apparently immunocompetent hosts.

Observation:

  • A 55-year-old immunocompetent male with heavy alcohol use presented with stroke symptoms.
  • Initial treatment targeted tuberculous meningitis and varicella-zoster virus vasculopathy.
  • Cerebrospinal fluid analysis revealed unexpected fungal infection.

Findings:

  • Multiplex polymerase chain reaction (PCR) assay of cerebrospinal fluid (CSF) rapidly identified Cryptococcus species.
  • Multilocus sequence typing (MLST) identified the strain as Cryptococcus neoformans var. grubii, ST5, VNI.
  • Early diagnosis via multiplex PCR led to swift treatment and a favorable outcome.

Implications:

  • Multiplex PCR assays are crucial for rapid, simultaneous detection of multiple pathogens, including unexpected ones.
  • This technology facilitates early diagnosis and treatment of invasive fungal infections like cryptococcosis.
  • Molecular diagnostic assays remain essential for accurate identification of infectious agents, complementing newer techniques.